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ABSTRACT
Background: Transient ischaemic attacks (TIAs) are
highly prevalent conditions, with at least 46 000 people
per year in the UK having a TIA for the first time. TIAs
are a warning that the patient is at risk of further
vascular events and the 90-day risk of vascular events
following a TIA, excluding events within the first week
after diagnosis when the risk is highest, can be as high
as 18%. Immediate assessment of patients with TIA,
either at accident and emergency, general practice and/
or TIA clinics, is therefore required to address
secondary prevention and prevent further vascular
events.
Discussion: This article addresses the need for
optimising secondary prevention in the acute period
following a TIA of ischaemic origin to reduce the risk
of further vascular events as per recent Cochrane
review advice and presents a novel project, Stroke
Prevention Rehabilitation Intervention Trial of Exercise
(SPRITE), to do this.
Summary: One novel way to tackle vascular risk
factors and promote secondary prevention in patients
with TIA could be to adapt a cardiac rehabilitation
programme for these patients. SPRITE, a feasibility and
pilot study (ClinicalTrials.gov Identifier: NCT02712385)
funded by the National Institute for Health Research, is
attempting to adapt a home-based cardiac
rehabilitation programme, ‘The Healthy Brain
Rehabilitation Manual’, for use in the acute period
following a TIA. The use of cardiac rehabilitation
programmes post-TIA requires further research,
particularly within the primary care setting.
BACKGROUND
Definition of transient ischaemic attack
Transient ischaemic attack (TIA) is defined
as ‘a transient episode of neurological
dysfunction caused by focal brain, spinal
cord or retinal ischaemia, without acute
infarction’1 and is diagnosed by the
patients’ history, a neurological examina-
tion and/or neuroimaging (typically a CT
head scan). Typical symptoms of TIA
include the rapid onset of speech distur-
bance, unilateral weakness or sensory loss,
monocular blindness, visual field defect or
ataxia.
Aetiology of TIAs: TOAST classification system
The underlying aetiology of each TIA event
can be classified as per the TOAST classifi-
cation system.2 The TOAST classification
denotes the underlying cause of the TIA
event and this paper focuses on secondary
prevention following a TIA due to athero-
sclerosis or small vessel occlusion, two
TOAST subtypes.
TIA risk factors
TIAs are most commonly caused by the
embolic or thrombotic consequences of
atherothrombotic disease,3 which is similar
to the underlying pathological mechanism
for cardiovascular disease.4–6 In addition to
sharing a similar underlying pathological
mechanism, cerebrovascular and cardiovas-
cular disease share common underlying risk
factors.5 7
The modifiable risk factors for all vascular
diseases include smoking, excessive alcohol
intake, physical inactivity, dietary factors,
What this study adds?
" Following a transient ischaemic attack (TIA),
people are at risk of further cardiovascular
events and this is a key time to initiate
secondary cardiovascular prevention.
" Previous studies have focused on pharmaco-
logical secondary prevention following a TIA.
" However, there is a clear need to initiate non-
pharmacological secondary cardiovascular
measures, including physical activity promo-
tion, following a TIA.
" One way to promote both pharmacological and
non-pharmacological secondary cardiovascular
prevention following a TIA is to adapt a home-
based cardiac rehabilitation programme, ‘The
Healthy Brain Rehabilitation Manual’, for this
population following the Medical Research
Council guidelines for developing complex
health service interventions, which will be done
within the Stroke Prevention Rehabilitation
Intervention Trial of Exercise study.
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hypertension, dyslipidaemia, diabetes and obesity8 as
well as low VO2max.
9
Thus, there are several lifestyle modifications that
might contribute to a substantial reduction in the risk
of vascular events post-TIA and there is evidence that
the earlier these interventions can be introduced, the
better the outcome.10 11
Pharmacological secondary prevention of stroke
National UK guidelines for the pharmacological treat-
ment of TIA/stroke have been established by the
National Institute for Health and Care Excellence
(NICE)12 and are supplemented by guidelines on tack-
ling individual risk factors. Following the acute
diagnosis of TIA, a prophylactic daily dose of 75 mg of
aspirin should be initiated and other agents, for
example, dipyridamole and clopidogrel, may be
added. These agents reduce blood clotting and there-
fore reduce the chances of a future clot forming within
the circulation. Statins should be initiated to lower
cholesterol levels13 and appropriate antihypertensive
medications are used for blood pressure control14 as
per national management guidelines. However,
evidence is growing regarding the contribution of
change in modifiable risk factors to reductions in
deaths15 and there is a need to consider how to
promote non-pharmacological measures within
secondary prevention.16
Non-pharmacological/ lifestyle risk factors
Physical activity
Physical activity promotion and participation must be
one of the key goals for modern-day health systems.
Indeed, the WHO in 201017 identified physical inac-
tivity as the fourth leading risk factor for global
mortality and this equates to 6% of global deaths.
Following a TIA, patients should be encouraged to
achieve at least the minimum recommended levels of
physical activity as established by the chief medical offi-
cers and the departments of health.18
Cardiorespiratory fitness
Related to physical activity is cardiorespiratory fitness,
which can be measured by VO2max, and is inversely
correlated with mortality,19–22 the progression of
carotid atherosclerosis23 and the risk of stroke.24 Myers
et al
25 found that in male subjects with and without
cardiovascular disease, peak exercise capacity after
adjustment for age was the strongest predictor of the
risk of death and each one metabolic equivalent increase
in exercise capacity conferred a 12% improvement in
survival.
Exercise, a form of physical activity, can increase
VO2max in sedentary persons
26 and in subacute stroke
survivors.27
Smoking
Smoking is a well-recognised vascular risk factor. The
landmark prospective observational study by Doll
et al
28 found that British male doctors born between
1900 and 1930 who continued to smoke had a life
expectancy 10 years less than that of lifelong non-
smokers. Smoking as a vascular risk factor has been
continually supported by other studies,15 29 30 and
patients with TIA should be advised about smoking
cessation.31
Diet
With regards to diet, a recent meta-analysis has shown
that dietary fibre is inversely correlated with the risk of
stroke,32 with fish oils also being protective.33 Indeed
the ‘Mediterranean diet’ has shown favourable effects
on cardiovascular risk factors.34 Moreover, hypercho-
lesterolaemia, of which dietary intake may be a source,
is a modifiable risk factor for cardiovascular and cere-
brovascular diseases.35 Cholesterol levels were found to
be positively associated with the risk of non-haemor-
rhagic stroke,36 and dyslipidaemia was also a
significant risk factor for ischaemic stroke in the
INTERSTROKE study.37 Patients with TIA should,
therefore, be advised accordingly about their dietary
habits.
Stress
Psychological distress is a well-known risk factor for
TIAs. In the observational study by Everson-Rose
et al,386749 adults free of vascular disease at baseline in
the USA, aged 45–84 years old, were followed up for a
median of 8.5 years as part of the Multi-Ethnic Study
of Atherosclerosis. The authors found that higher
levels of stress and depressive symptoms were associ-
ated with increased TIA risk, independent of other
known vascular risk factors. Moreover, the diagnosis of
TIA often leaves survivors with stress, anxiety and
depressive symptoms. Indeed, a recent systematic
review39 has highlighted the prevalence of these often
forgotten symptoms following a TIA and/or stroke
diagnosis. Patients should therefore be educated about
the signs and symptoms to be aware of and signposted
appropriately for further management, with the
general practitioner often as their first contact.
Alcohol
Alcohol excess is a well-known modifiable vascular risk
factor, including for TIAs. Gill et al40 report the ‘J-
shaped’ association between alcohol and risk of stroke
in a case–control study of approximately 1200
patients, that is, low alcohol consumption may have a
protective effect for cerebrovascular events, whereas
heavy consumption predisposes to TIAs. Safe alcohol
consumption levels should therefore be promoted to
patients with TIA to reduce the risk of future vascular
events.41
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DISCUSSION
The ‘evidence gap’ from research to practice
Despite the knowledge surrounding vascular risk
factors and the recognition that TIAs are often the
precursors of disabling strokes, more needs to be done
in reducing stroke as the leading cause of adult
disability.42 Indeed the WHO, as part of their 2013
Global Action Plan For the Prevention and Control of
Non-Communicable Diseases, is trying to target a 25%
relative risk reduction in overall mortality from cardio-
vascular diseases, including TIAs.43
One novel way to tackle vascular risk factors and
promote secondary prevention in patients with TIA
could be to adapt a cardiac rehabilitation programme
for these patients. Indeed cardiovascular and cere-
brovascular diseases share common underlying
pathological mechanisms and risk factors. Moreover,
cardiac rehabilitation after a myocardial infarction
results in a statistically significant reduction in reinfarc-
tion (OR 0.53), cardiac mortality (OR 0.64) and all-
cause mortality (OR 0.74),44 and these findings concur
with those of a recent Cochrane review.45 Although
Heran et al45 report that the studies included in the
review mainly comprise middle-aged men, who are
generally at low cardiovascular risk and this should be
considered when developing future studies in this area.
A Cochrane review46 also demonstrated that hospital-
and home-based cardiac rehabilitation programmes
result in similar health gains, with home-based
programmes improving adherence to the programme47
and promoting longer-term sustainability of health
benefits.48
The Stroke Prevention Rehabilitation Intervention
Trial of Exercise (SPRITE) is a feasibility and pilot
study (ClinicalTrials.gov Identifier: NCT02712385)
funded by National Institute for Health Research
(NIHR), which is attempting to adapt a home-based
cardiac rehabilitation programme for use in the acute
period following a TIA. The WHO has defined cardiac
rehabilitation as the, ‘sum of activity and interventions
required to ensure the best possible physical, mental
and social conditions so that patients with chronic or
post-acute cardiovascular disease may, by their own
efforts, preserve or resume their proper place in
society and lead an active life’.49
NICE have recommended that the components of
cardiac rehabilitation should include exercise, health
education and stress management,50 helping to tackle
the known vascular risk factors as previously docu-
mented. Health education would include addressing the
known modifiable vascular risk factors as well as advice
regarding work, mental health and sexual activity.50
These components will all be addressed within our
adapted home-based cardiac rehabilitation programme,
‘The Healthy Brain Rehabilitation Manual’. Such
research has immediate clinical significance and the
potential to change guidelines for the management of
TIAs, as well as the potential to reduce morbidity and
mortality resulting from TIAs, with clear benefit to
patients.
SUMMARY
One novel way to tackle vascular risk factors and
promote secondary prevention in patients with TIA
could be to adapt a cardiac rehabilitation programme
for these patients. SPRITE, a feasibility and pilot study
(ClinicalTrials.gov Identifier: NCT02712385), is
attempting to adapt a home-based cardiac rehabilita-
tion programme, ‘The Healthy Brain
Rehabilitation Manual’, for use in the acute period
following a TIA. The use of cardiac rehabilitation
programmes post-TIA requires further research,
particularly within the primary care setting.
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